Sort
15,842 grants matching “pancreatic cancer”
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA
The Antigen Targeting Core
$959,871Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$959,255Martin W Brechbiel · Clinical Sciences · Z01 · FY2007 · CA
Administrative Core: Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$958,628Sanku Mallik · North Dakota State University · P20 · FY2018 · GM
Evolution of Primary and Resistant Solid Tumors
$958,557Dana-Farber Cancer Institute · U01 · FY2005 · CA
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
$958,436Rohit N. Kulkarni · Joslin Diabetes Center · U01 · FY2022 · DK
Novel approaches to improve prediction of cancer-associated thrombosis
$957,703Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · HL
Genetic Epidemiology of Cancer
$957,336Joan E. Bailey-Wilson · Human Genome Research · Z01 · FY2007 · HG
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
$956,721Bumsoo Han · Purdue University · U01 · FY2022 · CA
Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen
$956,150William A. Garland · Tosk, Inc. · R44 · FY2018 · CA
Targeting LIF/LIFR in pancreatic cancer
$956,072Hareesh Babu Nair · Evestra, Inc. · R44 · FY2021 · CA
Mechanisms governing metastatic dormancy and reactivation
$955,499Filippo G Giancotti · Columbia University Health Sciences · R35 · FY2022 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)
$955,352Ajit Harishkumar Goenka · Mayo Clinic Rochester · R01 · FY2025 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
$955,015Michael Karin · University Of California, San Diego · U01 · FY2023 · CA
Using markers to improve pancreatic cancer screening and surveillance
$954,328Michael G. Goggins · Johns Hopkins University · U01 · FY2018 · CA
Non-invasive staging of Metastasis by Precision MRI
$954,220Jenny J Yang · Inlighta Biosciences, Llc · R44 · FY2022 · CA
Novel approaches to improve prediction of cancer-associated thrombosis
$953,390Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2019 · HL
Using markers to improve pancreatic cancer screening and surveillance
$953,081Michael G. Goggins · Johns Hopkins University · U01 · FY2017 · CA
Molecular Imaging and Theranostics of Cancer
$952,718Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2019 · CA
Biology and Function of Exosomes in Cancer
$952,559Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$952,123Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$952,089Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
GENERAL CLINICAL RESEARCH CENTER
$951,937Medical University Of South Carolina · M01 · FY2000 · RR
NOVEL DZ-ARTEMISININ FOR TREATMENT OF PANCREATIC CANCER
$951,659Cedars-Sinai Medical Center · · FY2022 · Department of the Army
Studying factors controlling cancer progression and immune recognition in mouse models
$951,640Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2025 · CA